INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PetMed Express, Inc. – PETS GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. (“PetMed” or the “Company”) (NASDAQ: PETS). Such investors are advised to contact Danielle […]
(NYSE:CODI), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Compass Diversified Holdings (“CODI” or the “Company”) (NYSE: CODI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
(NASDAQ:ACB), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora Cannabis” or the “Company”) (NASDAQ: ACB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Aurora Cannabis and certain of its officers and/or
Founders Fuel Launches Botanical Performance Formula Designed Exclusively for High-Achieving Entrepreneurs Founders Fuel Unveils Revolutionary Cognitive Performance Solution GlobeNewswire July 01, 2025 Jupiter, Fl , July 01, 2025 (GLOBE NEWSWIRE) — Founders Fuel(R), the cognitive performance company trusted by top-tier executives, has launched its groundbreaking botanical performance formula, explicitly crafted for high-achieving entrepreneurs. This innovative
As Federal Tax Violation Cases Escalate in Laredo and Houston, Teakell Law Expands Focus on Vigorous Defense and Strategic Guidance GlobeNewswire July 01, 2025 Dallas, Texas, July 01, 2025 (GLOBE NEWSWIRE) — Teakell Law, a Dallas-based criminal defense firm led by former federal prosecutor John R. Teakell, announces an expanded focus on vigorous defense and
(NasdaqGM:RCKT), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. (“Rocket” or the “Company”) (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
(NYSE:OGN), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Organon & Co. (“Organon” or the “Company”) (NYSE: OGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sable Offshore Corp. – SOC GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Sable Offshore Corp. (“Sable” or the “Company”) (NYSE: SOC). Such investors are advised to contact Danielle
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Vera Bradley, Inc. – VRA GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Vera Bradley, Inc. (“Vera Bradley” or the “Company”) (NASDAQ: VRA). Such investors are advised to contact
(NASDAQ:TEM), NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc. (“Tempus” or the “Company”)(NASDAQ: TEM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing